Pankaj Mehta, MD
Interventional Pain Medicine · Killeen, TXNPI 1073787909
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Abbott at 45.8% of the total. Among interventional pain medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 3,214 payments — averaging $657.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$968K
- Boston Scientific$356K
- Aurora Spine, Inc.$324K
- Vertiflex, Inc.$187K
- Spinal Simplicity, LLC$144K
- Relievant Medsystems, Inc.$49K
- plus $84K from 28 others
Across 60 payments — averaging $810.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$36K
- Boston Scientific$12K
Across 3 payments — averaging $6142.49 each. An ownership or investment interest held by the physician or an immediate family member.
- Spinal Simplicity, LLC$18K
What the payments were for
- Royalty or licence$37,5322%
- Consulting fees$731,15435%
- Speaking & faculty fees$1,080,50751%
- Travel & lodging$129,0906%
- Food & beverage$93,4934%
- Education$40,1082%
- Entertainment$2970%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 2,130 | $967,995 |
| Boston Scientific | 291 | $355,611 |
| Aurora Spine, Inc. | 35 | $324,131 |
| Vertiflex, Inc. | 213 | $186,905 |
| Spinal Simplicity, LLC | 161 | $144,380 |
| Relievant Medsystems, Inc. | 90 | $49,031 |
| Surgentec | 9 | $37,010 |
| Painteq LLC | 119 | $24,609 |
| SPR Therapeutics, Inc | 11 | $10,622 |
| Foundation Fusion Solutions, LLC | 28 | $2,159 |
| Nevro Corp. | 25 | $2,017 |
| Spinefrontier, Inc. | 4 | $1,839 |
| Medtronic(2 entities) | 31 | $1,831 |
| Globus Medical | 16 | $684 |
| Biotronik NRO, Inc. | 7 | $584 |
| Nalu Medical, Inc. | 11 | $562 |
| MML US, Inc. | 4 | $507 |
| Vertos Medical, Inc. | 6 | $270 |
| Saluda Medical Americas, Inc. | 2 | $239 |
| Si-bone, Inc. | 3 | $193 |
| Curonix LLC | 2 | $161 |
| Bioventus LLC | 2 | $146 |
| Zynex Medical, Inc. | 1 | $131 |
| Riwospine, Inc. | 1 | $131 |
| Wenzel Spine, Inc. | 1 | $118 |
| Flowonix Medical Incorporated | 1 | $80 |
| Fujifilm Sonosite, Inc. | 1 | $78 |
| Stimwave Technologies Incorporated | 1 | $44 |
| GRT US Holding, Inc. | 3 | $32 |
| Scilex Pharmaceuticals Inc. | 1 | $22 |
| Hydrocision, Inc. | 1 | $17 |
| AbbVie | 1 | $16 |
| Davol Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$464,815
- ZIP$296,426
- Neuromodulation Dspsbls and Accs$248,279
- SUPERION$220,559
- Superion ISS$183,206
- HA MINUTEMAN G3-R$141,950
- Intracept$104,990
- VERIFLEX$64,350
- Proclaim DRG IPG$52,335
- Proclaim Family of SCS IPGs$47,633
- Proclaim IPG$42,279
- IonicRF Generator$37,213
- Superion Indirect Decompression System$34,754
- DISCOVERY TINANO ACIF$27,706
- PAINTEQ$21,664
- ION Facet Screw System$17,853
- TiLinki$13,944
- ION$12,907
- Axium INS DRG IPG$10,586
- SPRINT PNS System$10,503
How this compares
$2,112,181 in reported general payments places this provider in the 95th percentile of 287 interventional pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 584 | $11,586 |
| NucyntaTapentadol Hcl | 11 | $7,029 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 91 | $1,664 |
| Morphine Sulfate ErMorphine Sulfate | 25 | $680 |
| Mupirocin | 63 | $496 |
| Tizanidine Hcl | 54 | $350 |
| Oxycodone Hcl | 24 | $270 |
| Gabapentin | 43 | $234 |
| Cephalexin | 51 | $188 |
| Tramadol Hcl | 15 | $69 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Killeen
- Shawn PuriKilleen$37K
- Kristian DelgadoKilleen$30K
- Bradley CullingKilleen$24K
- Gabor RaczLubbock$3M
- Chad StephensSouthlake$1M
- Ankur KhoslaShenandoah$277K
- Brian RichDecatur$245K
- Brian BruelHouston$219K
- Bolkar SahinlerLubbock$188K
- Timothy RatinoFort Worth$139K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.